Drug:
Reaction: WEIGHT DECREASED
20250101 - 20251231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 25110732 |
US |
2 | |
Off label use, Pulmonary hypertension, Graves^ disease, Pain, Asthenia, Depression, Weight decreased, |
||||
RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 202 | 25111158 |
US |
2 | |
Weight decreased, Malabsorption, |
||||
PANCRELIPASE, |
||||
| 203 | 25111458 |
US |
79 | 1 |
Gastrointestinal haemorrhage, Asthenia, Weight decreased, Spinal column injury, Respiratory disorder, |
||||
AVALGLUCOSIDASE ALFA, |
||||
| 204 | 25111507 |
CA |
55 | 2 |
Acne, Blood pressure systolic increased, Dermal cyst, Erythema, Eye pain, Feeling hot, Haemorrhage urinary tract, Headache, Hypersensitivity, Inappropriate schedule of product administration, Livedo reticularis, Major depression, Mental fatigue, Middle insomnia, Oxygen saturation decreased, Paraesthesia, Product dose omission issue, Pruritus, Rash, Skin burning sensation, Skin irritation, Skin plaque, Skin swelling, Stress, Suicidal ideation, Urinary tract infection, Urticaria, Weight decreased, Drug ineffective, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CLONIDINE, DEXLANSOPRAZOLE, LORAZEPAM, MONTELUKAST, NABILONE, OXAZEPAM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 205 | 25111534 |
CA |
2 | |
Type 2 diabetes mellitus, Gait disturbance, Alopecia, Malaise, Back disorder, Fluid retention, Liver injury, Injury, Hypertension, Nausea, Sleep disorder, Memory impairment, Vomiting, Wound, Glossodynia, Hypoaesthesia, Blood cholesterol increased, Hepatic enzyme increased, Helicobacter infection, Oedema, Rash vesicular, Swelling, Abdominal discomfort, Diarrhoea, Pulmonary fibrosis, Anti-cyclic citrullinated peptide antibody positive, Stomatitis, Infusion related reaction, Pain, Breast cancer stage II, Decreased appetite, Peripheral swelling, X-ray abnormal, Pain in extremity, Grip strength decreased, Joint range of motion decreased, Dyspnoea, Pneumonia, General physical health deterioration, Dyspepsia, Psoriatic arthropathy, Mobility decreased, Pericarditis, Arthropathy, Gait inability, Joint swelling, Dislocation of vertebra, Drug hypersensitivity, Hypercholesterolaemia, Impaired healing, Condition aggravated, Psoriasis, Fatigue, Swollen joint count increased, Weight increased, Synovitis, Fibromyalgia, Folliculitis, Nasopharyngitis, Pruritus, Systemic lupus erythematosus, Infection, Abdominal pain upper, Contusion, Confusional state, Duodenal ulcer perforation, Muscle injury, Urticaria, Ill-defined disorder, Wound infection, Wheezing, Headache, Gastrointestinal disorder, Blister, Rash, Lower respiratory tract infection, Hypersensitivity, Subcutaneous drug absorption impaired, Irritable bowel syndrome, Myositis, Weight decreased, Chest pain, Sinusitis, Delirium, Discomfort, Depression, Arthralgia, Rheumatic fever, General symptom, Pemphigus, Amnesia, Migraine, Adjustment disorder with depressed mood, Sleep disorder due to general medical condition, insomnia type, Hand deformity, Musculoskeletal stiffness, Pustular psoriasis, Rheumatoid arthritis, Pyrexia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CALCIUM CARBONATE, VITAMIN C, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, NAPROXEN, NAPROXEN SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SECUKINUMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, LISINOPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RAMIPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LANSOPRAZOLE, DESOGESTREL AND ETHINYL ESTRADIOL, CAFFEINE CITRATE, CALCIUM GLUCONATE, LORAZEPAM, ALENDRONATE SODIUM, |
||||
| 206 | 25111643 |
GB |
2 | |
Weight decreased, Nausea, Vomiting, Abdominal pain lower, |
||||
LANREOTIDE ACETATE, |
||||
| 207 | 25111974 |
FR |
69 | 1 |
General physical condition abnormal, Incontinence, Bronchitis, Weight decreased, Communication disorder, Dehydration, |
||||
| 208 | 25112026 |
US |
1 | |
Pain in extremity, Condition aggravated, Catatonia, Weight decreased, Feeding disorder, Fluid intake reduced, Decreased activity, Gait disturbance, |
||||
FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE, |
||||
| 209 | 25112137 |
CA |
44 | 2 |
Pulmonary fibrosis, Pruritus, Wound infection, Rectal haemorrhage, Weight fluctuation, Retinitis, Pericarditis, Swollen joint count increased, Vomiting, Swollen joint count, Urticaria, Wheezing, Road traffic accident, Pneumonia, Rheumatoid factor positive, Injury, Swelling, Pyrexia, Sleep disorder due to a general medical condition, White blood cell count increased, Maternal exposure during pregnancy, Type 2 diabetes mellitus, Rheumatic fever, Peripheral swelling, Synovitis, Sinusitis, Weight decreased, Peripheral venous disease, Rheumatoid arthritis, Visual impairment, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Weight increased, Rash, Wound, Pemphigus, Systemic lupus erythematosus, Sciatica, Psoriatic arthropathy, Porphyria acute, |
||||
CALCIUM CARBONATE, ALBUTEROL SULFATE, ALBUTEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, MELOXICAM, LANSOPRAZOLE, APREMILAST, APREMILAST, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, FLUOROMETHOLONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, PREDNISONE, PREDNISONE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, RAMIPRIL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CAFFEINE, LANSOPRAZOLE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, MORPHINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, LORAZEPAM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, SECUKINUMAB, SECUKINUMAB, LORAZEPAM, ERYTHROMYCIN, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, USTEKINUMAB, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, SECUKINUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEFLUNOMIDE, HYALURONIDASE, LISINOPRIL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, MAGNESIUM, TOFACITINIB, APREPITANT, FOSAPREPITANT DIMEGLUMINE, PREGABALIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, MESALAMINE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, TOFACITINIB, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LISINOPRIL, RITUXIMAB, RITUXIMAB, |
||||
| 210 | 25112167 |
US |
10 | 1 |
Seizure, Weight decreased, Feeding tube user, Therapeutic response decreased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, PHENOBARBITAL, |
||||
| 211 | 25112178 |
CA |
2 | |
Rheumatoid factor positive, Road traffic accident, Sciatica, Seronegative arthritis, Sinusitis, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MESALAMINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, PREGABALIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SALICYLIC ACID, MEDICATED CORN REMOVERS, LIQUID WART REMOVER, ULTRA THIN CORN REMOVERS, MEDICATED PLANTAR WART REMOVER, EXTRA THICK CALLUS REMOVERS, CORN AND CALLUS REMOVER KIT, WART REMOVERS, WART REMOVER LIQUID, MEDICATED CALLUS REMOVERS, MEDICATED CALLUS REMOVERS EXTRA THICK, WART REMOVER GEL, WART REMOVER, CLEAR MEDICATED CORN REMOVERS, CORN REMOVERS, BOSYE BENEFITING HAIR LOTION, GEL CALLUS REMOVER, CALLUS REMOVERS, LIQUID CORN AND CALLUS REMOVER, WART REMOVER MEDICATED DISCS, WART REMOVER GEL TUBE, CORN AND CALLUS REMOVER LIQUID, PLANTAR WART REMOVER, ASTRINGENT, CORN AND CALLUS REMOVER, MEDICATED CORN REMOVER, GEL CORN REMOVER, HYDROGEL CLEAR WART REMOVER, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, |
||||
| 212 | 25112307 |
US |
1 | |
Weight decreased, COVID-19, Physical disability, Soliloquy, |
||||
BRIVARACETAM, |
||||
| 213 | 25112319 |
US |
2 | |
Injection site mass, Back pain, Weight decreased, Wrong technique in product usage process, |
||||
LANREOTIDE ACETATE, LANREOTIDE ACETATE, |
||||
| 214 | 25112359 |
US |
73 | 2 |
Hernia, COVID-19 pneumonia, Skin cancer, Cerebral haemorrhage, Polymyositis, Weight decreased, Dizziness, Headache, Vomiting, Feeling jittery, Nausea, Balance disorder, Diarrhoea, Constipation, Diarrhoea, Post procedural complication, Fatigue, Pyrexia, Scoliosis, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 215 | 25112372 |
PK |
62 | 2 |
Weight decreased, Liver disorder, Neoplasm malignant, |
||||
BEVACIZUMAB, BEVACIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, |
||||
| 216 | 25112392 |
US |
2 | |
Decreased appetite, Weight decreased, Off label use, |
||||
BRIVARACETAM, CANNABIDIOL, CANNABIDIOL, |
||||
| 217 | 25112400 |
US |
1 | |
Weight decreased, |
||||
BRIVARACETAM, |
||||
| 218 | 25112419 |
US |
27 | 2 |
Aggression, Agitation, Weight decreased, Therapeutic response shortened, |
||||
BRIVARACETAM, |
||||
| 219 | 25112430 |
US |
27 | 2 |
Aggression, Agitation, Weight decreased, Therapeutic response shortened, Inappropriate schedule of product administration, |
||||
BRIVARACETAM, |
||||
| 220 | 25112541 |
US |
2 | |
Injection site pain, Fatigue, Weight decreased, Erythema, Pruritus, Burning sensation, Skin lesion, Psoriasis, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 221 | 25112658 |
CA |
29 | 2 |
Urticaria, Weight decreased, Injection site pain, Incorrect dose administered, Needle issue, Erythema, Skin irritation, Pruritus, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, LORATADINE, LORATADINE TABLET, CIPROFLOXACIN HYDROCHLORIDE, |
||||
| 222 | 25112875 |
US |
57 | |
Weight decreased, Impaired gastric emptying, Nausea, Vomiting, Diarrhoea, |
||||
DULAGLUTIDE, |
||||
| 223 | 25112894 |
GB |
57 | 1 |
Weight decreased, Diarrhoea, Malaise, |
||||
TIRZEPATIDE, AMLODIPINE, |
||||
| 224 | 25113012 |
US |
2 | |
Weight decreased, |
||||
BIMEKIZUMAB, |
||||
| 225 | 25113326 |
1 | ||
Weight decreased, Constipation, Blood potassium decreased, Therapy interrupted, |
||||
TAFAMIDIS, DAPAGLIFLOZIN, |
||||
| 226 | 25113470 |
US |
64 | 1 |
Pancreatic cyst, Asthenia, Enzyme level decreased, Pancreatic enzymes decreased, Blood insulin decreased, Weight decreased, Diarrhoea, |
||||
PANCRELIPASE, |
||||
| 227 | 25113479 |
CA |
36 | 2 |
Diabetes mellitus, Asthma, Malaise, Metabolic disorder, Sneezing, Urticaria, Body mass index increased, Cough, Drug ineffective, Dyspnoea, Food allergy, Glucose tolerance impaired, Injection site bruising, Diarrhoea, Insomnia, Weight increased, Lung disorder, Wheezing, Fatigue, Nausea, Lethargy, Weight decreased, COVID-19, Skin sensitisation, Inappropriate schedule of product administration, Vomiting, Middle insomnia, Blood pressure increased, Sinus disorder, Product dose omission issue, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, ESCITALOPRAM OXALATE, ESCITALOPRAM, MEDROXYPROGESTERONE ACETATE, |
||||
| 228 | 25113716 |
US |
55 | 1 |
Weight decreased, Diarrhoea, Poor quality product administered, Product dose omission issue, Product odour abnormal, Product colour issue, Product taste abnormal, Product physical issue, |
||||
ICOSAPENT ETHYL, |
||||
| 229 | 25113826 |
CO |
29 | 1 |
Anxiety, Alcohol abuse, Drug abuse, Physical assault, Intentional self-injury, Memory impairment, Shock, Weight decreased, Body height increased, Weight increased, Pregnancy of partner, Product dose omission issue, Body height decreased, Hereditary angioedema, |
||||
ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, ICATIBANT ACETATE, ICATIBANT, LANADELUMAB-FLYO, LANADELUMAB-FLYO, LANADELUMAB-FLYO, LANADELUMAB-FLYO, LANADELUMAB-FLYO, |
||||
| 230 | 25114033 |
US |
63 | 1 |
Dysphonia, Decreased appetite, Weight decreased, Glossodynia, Oral pain, |
||||
AXITINIB, |
||||
| 231 | 25114344 |
US |
2 | |
Weight decreased, |
||||
AGALSIDASE BETA, |
||||
| 232 | 25115098 |
BR |
53 | 2 |
Feeling abnormal, Metastases to bone, Metastasis, Decreased immune responsiveness, Diarrhoea, Abdominal pain upper, Retching, Vomiting, Alopecia, Gastrointestinal disorder, Hair disorder, Nausea, Hypophagia, Pruritus, Skin burning sensation, Dry skin, Malaise, Weight decreased, Urinary tract infection, Pyrexia, Chills, Mouth ulceration, Fatigue, Pain, White blood cell count decreased, Swelling, Skin disorder, Platelet count decreased, Helicobacter infection, Malaise, Asthenia, Bone pain, Anxiety, Depression, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 233 | 25109251 |
US |
1 | |
Pneumonia, Renal failure, Acute kidney injury, Renal impairment, Weight decreased, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 234 | 25109275 |
US |
61 | 1 |
Weight decreased, Throat irritation, Pneumonia, Nervousness, Gastrooesophageal reflux disease, Tremor, Feeling jittery, Cough, Dyspnoea, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 235 | 25109355 |
US |
56 | 2 |
Weight decreased, Decreased appetite, |
||||
ABEMACICLIB, ABEMACICLIB, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, LETROZOLE, LETROZOLE TABLETS, |
||||
| 236 | 25109490 |
US |
1 | |
Weight decreased, |
||||
AVALGLUCOSIDASE ALFA, |
||||
| 237 | 25109539 |
DE |
1 | |
Weight decreased, Muscle atrophy, |
||||
RIVAROXABAN, SPIRONOLACTONE, CANDESARTAN, |
||||
| 238 | 25107625 |
JP |
60 | |
Radiotherapy, Weight decreased, White blood cell count decreased, Diarrhoea, Platelet count decreased, |
||||
PEMBROLIZUMAB, CISPLATIN, |
||||
| 239 | 25107629 |
GR |
73 | 2 |
Hypophagia, Mobility decreased, Mental disorder, Weight decreased, Fluid intake reduced, Somnolence, |
||||
RIFAXIMIN, SACCHAROMYCES CEREVISIAE, |
||||
| 240 | 25107824 |
US |
66 | 1 |
Diarrhoea, Dehydration, Weight decreased, |
||||
SARILUMAB, |
||||
| 241 | 25108096 |
US |
59 | 2 |
Weight decreased, |
||||
DUPILUMAB, |
||||
| 242 | 25108205 |
US |
74 | 2 |
Hypertension, Weight decreased, Abdominal pain upper, Hepatic pain, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 243 | 25108238 |
US |
72 | 1 |
Angina pectoris, Weight decreased, |
||||
EMPAGLIFLOZIN, |
||||
| 244 | 25108341 |
US |
86 | 2 |
Papule, Weight decreased, Diarrhoea, Rash, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DUPILUMAB, EMPAGLIFLOZIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 245 | 25108729 |
US |
80 | 2 |
Implantable defibrillator insertion, Cough, Weight decreased, Joint range of motion decreased, Dysphonia, Increased upper airway secretion, |
||||
ADALIMUMAB, MIRABEGRON, ALBUTEROL SULFATE, ALBUTEROL, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, OXYBUTYNIN, FOLIC ACID, MONTELUKAST, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CETIRIZINE HYDROCHLORIDE, METOPROLOL SUCCINATE, ALBUTEROL SULFATE, ALBUTEROL, LEVOTHYROXINE, |
||||
| 246 | 25108893 |
RO |
33 | |
HIV-associated neurocognitive disorder, Paresis, Drug resistance, Portal hypertension, Weight decreased, Malabsorption, Ill-defined disorder, HIV infection CDC category C, Interstitial lung disease, Oral candidiasis, Anaemia, |
||||
LOPINAVIR AND RITONAVIR, LAMIVUDINE, LAMIVUDINE ORAL, RALTEGRAVIR, EFAVIRENZ, LAMIVUDINE AND ZIDOVUDINE, |
||||
| 247 | 25102520 |
US |
2 | |
Weight decreased, |
||||
OMALIZUMAB, |
||||
| 248 | 25102521 |
US |
||
Weight decreased, |
||||
OMALIZUMAB, |
||||
| 249 | 25102689 |
US |
72 | 2 |
Accidental underdose, Weight decreased, Dehydration, Urinary tract infection, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 250 | 25102712 |
US |
58 | 1 |
Weight decreased, |
||||
INEBILIZUMAB, INEBILIZUMAB, |
||||
| 251 | 25102873 |
US |
82 | 1 |
Flatulence, Weight decreased, Constipation, Diarrhoea, |
||||
NINTEDANIB, |
||||
| 252 | 25103007 |
US |
77 | 1 |
Immobile, Unresponsive to stimuli, Weight decreased, Musculoskeletal stiffness, Blood pressure abnormal, Persecutory delusion, Anxiety, Agitation, Aggression, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 253 | 25103041 |
US |
90 | 2 |
Pneumonia, Cough, Decreased appetite, Lower respiratory tract congestion, Lung disorder, Nausea, Dizziness, Oral discomfort, Weight decreased, |
||||
TREPROSTINIL, TREPROSTINIL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, MACITENTAN, RIOCIGUAT, ALPRAZOLAM, AMLODIPINE BESYLATE, PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION, SODIUM ZIRCONIUM CYCLOSILICATE, DENOSUMAB, CARBAMIDE PEROXIDE, ROSUVASTATIN CALCIUM, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, PREGABALIN, CETIRIZINE HCL, CETIRIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, ALPRAZOLAM, BENZONATATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CHLORHEXIDINE GLUCONATE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, |
||||
| 254 | 25103098 |
US |
70 | 2 |
Colon cancer, Food refusal, Diarrhoea, Weight decreased, Immunosuppression, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 255 | 25103100 |
CA |
63 | 2 |
Arthritis infective, Back pain, Blood pressure systolic increased, Bronchitis, Chest discomfort, Chest pain, Cystitis, Forced expiratory volume decreased, Gait inability, Gastrooesophageal reflux disease, Hypoaesthesia, Ill-defined disorder, Lung hyperinflation, Middle insomnia, Muscle tightness, Musculoskeletal discomfort, Nasopharyngitis, Obstructive airways disorder, Postoperative wound complication, Respiratory gas exchange disorder, Rotator cuff syndrome, Skin infection, Thermal burn, Weight decreased, Wound secretion, Pain, Paraesthesia, Upper respiratory tract infection, Arthralgia, Asthma, Dizziness, Viral pharyngitis, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, MONTELUKAST SODIUM, |
||||
| 256 | 25103173 |
US |
20 | 2 |
Loss of consciousness, Blood potassium decreased, Blood calcium increased, Vertigo, Feeling abnormal, Insomnia, Hypophagia, Sleep deficit, Initial insomnia, Poor quality sleep, Muscle spasms, Somnolence, Weight decreased, Fatigue, Dizziness, Nausea, Vomiting, |
||||
SEMAGLUTIDE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, LITHIUM, LITHIUM BROMATUM, QUETIAPINE, CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, MODAFINIL, PITOLISANT HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE, LEVONORGESTREL, |
||||
| 257 | 25103197 |
GB |
43 | 1 |
Medication error, Weight decreased, Completed suicide, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 258 | 25103221 |
US |
||
Weight decreased, Fatigue, |
||||
VORICONAZOLE, |
||||
| 259 | 25103545 |
NL |
87 | 2 |
Death, Infusion site erythema, Infusion site infection, Device difficult to use, Loss of personal independence in daily activities, Weight decreased, Terminal state, |
||||
PRAMIPEXOLE, CLOZAPINE, RIVASTIGMINE, |
||||
| 260 | 25103566 |
US |
89 | 2 |
Constipation, Fatigue, Weight decreased, Peripheral swelling, Alopecia, |
||||
LENALIDOMIDE, |
||||
| 261 | 25103879 |
FR |
64 | 2 |
Condition aggravated, Weight decreased, Polyuria, Polydipsia, |
||||
EMPAGLIFLOZIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TIOTROPIUM BROMIDE, |
||||
| 262 | 25103919 |
US |
1 | |
Weight decreased, Off label use, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
| 263 | 25104070 |
CA |
64 | 2 |
Abdominal pain upper, Arthralgia, Asthma, Autoimmune disorder, Back pain, Biliary colic, Blood pressure systolic increased, Chest pain, Cholecystitis, Confusional state, Cough, Dry mouth, Dyspnoea, Exposure to allergen, Fatigue, Feeling abnormal, Feeling cold, Feeling of body temperature change, Forced expiratory volume decreased, Gait disturbance, Gastroenteritis viral, Gingival recession, Headache, Heart rate increased, Hyperhidrosis, Illness, Inappropriate schedule of product administration, Inflammation, Influenza, Lumbar vertebral fracture, Middle insomnia, Migraine, Muscle spasms, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Obstructive airways disorder, Oral disorder, Oropharyngeal pain, Pain, Pancreatitis, Pneumonia, Post procedural complication, Pyrexia, Therapeutic response decreased, Type 2 diabetes mellitus, Vomiting, Weight decreased, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MORPHINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE, BUDESONIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CLONIDINE, CLONIDINE, CLOZAPINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, PREGABALIN, PREGABALIN, PREGABALIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 264 | 25104783 |
PL |
77 | 1 |
Gastric ulcer, Weight decreased, Decreased appetite, |
||||
LENALIDOMIDE, LENALIDOMIDE, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 265 | 25104854 |
US |
||
Weight decreased, Swelling face, Fatigue, |
||||
TOVORAFENIB, TOVORAFENIB, |
||||
| 266 | 25104870 |
83 | 1 | |
Dizziness, Asthenia, Hypotension, Pneumonia aspiration, Weight decreased, Sepsis, Fatigue, Urinary tract infection, Acute kidney injury, Squamous cell carcinoma of the oral cavity, Tachypnoea, Respiratory failure, |
||||
PEMBROLIZUMAB, |
||||
| 267 | 25105005 |
CA |
74 | 2 |
Condition aggravated, Cough, Decreased appetite, Fall, Fatigue, Haemorrhoids, Illness, Malaise, Peripheral swelling, Weight decreased, Off label use, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, LANREOTIDE ACETATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EVEROLIMUS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, OCTREOTIDE ACETATE, OCTREOTIDE, ROSUVASTATIN, |
||||
| 268 | 25105327 |
US |
74 | 2 |
Diverticulitis, Headache, Weight decreased, Blood glucose fluctuation, |
||||
TIRZEPATIDE, INSULIN GLARGINE, |
||||
| 269 | 25105649 |
US |
83 | 2 |
Hyperhidrosis, Weight decreased, |
||||
BEMPEDOIC ACID, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 270 | 25105741 |
US |
2 | |
Weight decreased, |
||||
BUPRENORPHINE, |
||||
| 271 | 25105874 |
US |
1 | |
Feeding intolerance, Weight decreased, |
||||
TROFINETIDE, |
||||
| 272 | 25105938 |
US |
29 | 1 |
Weight decreased, Product storage error, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 273 | 25105939 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Exostosis, Fatigue, Fibromyalgia, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Rheumatic fever, Road traffic accident, Sciatica, Seronegative arthritis, Sleep disorder, Sleep disorder due to a general medical condition, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Walking aid user, Spinal fusion surgery, Hip arthroplasty, Crohn^s disease, Rheumatoid arthritis, Rheumatoid factor positive, Retinitis, Bronchitis, Laryngitis, Ear infection, Nasopharyngitis, Sinusitis, Folliculitis, Upper respiratory tract infection, Infection, Helicobacter infection, Pneumonia, Wound infection, Breast cancer stage III, Prescribed underdose, Prescribed overdose, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, AZATHIOPRINE, CALCIUM CARBONATE, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 274 | 25105963 |
US |
||
Weight decreased, Fatigue, Sluggishness, Drug ineffective, |
||||
GLIPIZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PIOGLITAZONE, DULAGLUTIDE, |
||||
| 275 | 25106170 |
US |
1 | |
Respiratory tract infection, Influenza, Wound infection, Hyperkeratosis, Weight decreased, Overweight, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 276 | 25106674 |
US |
||
Blood pressure fluctuation, Vomiting, Decreased appetite, Weight decreased, Diarrhoea, Asthenia, Nausea, Blood pressure decreased, Headache, |
||||
LENVATINIB, LISINOPRIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 277 | 25106730 |
CA |
50 | 2 |
Abdominal pain, Extrapyramidal disorder, Migraine, Neovascularisation, Weight decreased, Paradoxical drug reaction, Anuria, Cough, Diarrhoea, Dyspepsia, Dyspnoea, Nausea, Drug ineffective, Treatment failure, Drug ineffective for unapproved indication, Off label use, Product use in unapproved indication, Product use issue, |
||||
ATENOLOL, NAPROXEN, NAPROXEN SODIUM, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROCHLORPERAZINE, PROCHLORPERAZINE, PROCHLORPERAZINE, CANDESARTAN, CANDESARTAN, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ERENUMAB-AOOE, ERENUMAB-AOOE, AMLODIPINE BESYLATE, CLONIDINE, GABAPENTIN, GABAPENTIN, LAMOTRIGINE, RIZATRIPTAN BENZOATE, METOCLOPRAMIDE HYDROCHLORIDE, NIFEDIPINE, NIFEDIPINE, PREDNISONE, PREDNISONE, TOPIRAMATE, TOPIRAMATE, DIVALPROEX SODIUM, DIVALPROEX SODIUM, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, FROVATRIPTAN SUCCINATE, DIMENHYDRINATE, VALPROATE SODIUM, ATENOLOL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALLOPURINOL, VALPROIC ACID, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, DIVALPROEX SODIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, RIZATRIPTAN, ERENUMAB-AOOE, |
||||
| 278 | 25107064 |
CA |
31 | 1 |
Haematochezia, Ear infection bacterial, Cardiac pacemaker replacement, Blood creatine increased, Nephritis, Dermal cyst, Stress, Headache, Hypoacusis, Ear discomfort, Fatigue, Back pain, Insomnia, Decreased appetite, Procedural pain, Lower respiratory tract infection viral, Gastroenteritis, Influenza, Weight decreased, Dyspnoea, Myalgia, Bronchial disorder, |
||||
PREDNISONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 279 | 25107075 |
US |
66 | |
Weight decreased, Impaired gastric emptying, Nausea, Vomiting, Diarrhoea, |
||||
DULAGLUTIDE, |
||||
| 280 | 25107147 |
GB |
16 | 2 |
Blood creatine phosphokinase increased, Malaise, Myositis, Muscular weakness, Weight decreased, |
||||
| 281 | 25107199 |
IT |
2 | |
Death, Malignant neoplasm progression, Recurrent cancer, Pain, Discomfort, Weight decreased, General physical health deterioration, |
||||
CARBOPLATIN, DURVALUMAB, TREMELIMUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 282 | 25107279 |
US |
||
Weight decreased, Pruritus, |
||||
PANCRELIPASE, |
||||
| 283 | 25107317 |
AU |
67 | 1 |
Pulmonary embolism, Gallbladder disorder, Decreased appetite, Weight decreased, Fatigue, Dry skin, Dyspepsia, Taste disorder, Dysphonia, Constipation, Nausea, |
||||
LENVATINIB, LENVATINIB, PEMBROLIZUMAB, |
||||
| 284 | 25107484 |
US |
1 | |
Weight decreased, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 285 | 25097291 |
US |
63 | 1 |
Anaesthetic complication, Coronary artery disease, Gastric haemorrhage, Feeding disorder, Vomiting, Anaemia, Scar, Procedural complication, Weight decreased, |
||||
ADALIMUMAB, |
||||
| 286 | 25097321 |
US |
82 | 2 |
Heart rate increased, Influenza, Oedema peripheral, Weight decreased, Decreased appetite, Product dose omission issue, |
||||
MACITENTAN, TREPROSTINIL, FUROSEMIDE, FISH OIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TRIAMTERENE CAPSULES, TRIAMTERENE, ERGOCALCIFEROL, APIXABAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, VITAMIN C, OXYGEN, 0XYGEN, CALCIUM, MAGNESIUM, GUAIFENESIN, |
||||
| 287 | 25097578 |
US |
2 | |
Weight decreased, |
||||
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, |
||||
| 288 | 25097590 |
US |
33 | 2 |
Presyncope, Dehydration, Decreased appetite, Paraesthesia, Hypoaesthesia, Feeling cold, Malnutrition, Muscle atrophy, Weight decreased, Muscular weakness, Peripheral coldness, Photophobia, Ophthalmoplegia, Dizziness, Constipation, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 289 | 25097606 |
BR |
66 | 2 |
Hypertension, Lethargy, Blood pressure fluctuation, Weight decreased, Decreased appetite, |
||||
CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, INDAPAMIDE, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 290 | 25097643 |
US |
2 | |
Feeling abnormal, Back pain, Dizziness, Arthralgia, Feeding disorder, Nausea, Weight decreased, Constipation, Gastrointestinal disorder, Arthritis, |
||||
GABAPENTIN, LINACLOTIDE, |
||||
| 291 | 25097806 |
US |
2 | |
Headache, Weight decreased, Nausea, Diarrhoea, |
||||
APREMILAST, |
||||
| 292 | 25097830 |
US |
66 | 1 |
Abdominal pain upper, Arthralgia, Myalgia, Brain fog, Fatigue, Constipation, Weight decreased, Vision blurred, Vitreous floaters, Depression, Pruritus, Drug intolerance, |
||||
LENALIDOMIDE, |
||||
| 293 | 25097883 |
US |
77 | 1 |
Weight decreased, |
||||
DUPILUMAB, |
||||
| 294 | 25097919 |
CA |
2 | |
Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, CALCIUM GLUCONATE, DESOGESTREL AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 295 | 25097949 |
US |
2 | 1 |
Weight decreased, Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 296 | 25098035 |
CA |
79 | 1 |
Arthralgia, Arthropathy, Asthenia, COVID-19, Decreased appetite, Diabetes mellitus, Diarrhoea, Dyspnoea, Dysstasia, Fall, Gout, Hypotension, Injection site mass, Injection site pain, Mobility decreased, Muscular weakness, Myocardial infarction, Neuritis, Pain in extremity, Pleural effusion, Skin erosion, Tooth abscess, Condition aggravated, Weight decreased, Product use in unapproved indication, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 297 | 25098037 |
CA |
68 | 1 |
Influenza, Pulmonary oedema, Hypertension, Faeces soft, Blood pressure increased, Decreased appetite, Weight decreased, Abdominal pain upper, Dehydration, Diarrhoea, Fatigue, Nausea, Vomiting, |
||||
SEMAGLUTIDE, NINTEDANIB, |
||||
| 298 | 25098517 |
JP |
16 | 1 |
Epilepsy, Decreased appetite, Weight decreased, Off label use, Prescribed underdose, |
||||
FENFLURAMINE, |
||||
| 299 | 25098684 |
US |
2 | |
Diarrhoea, Weight decreased, |
||||
TROFINETIDE, |
||||
| 300 | 25098686 |
US |
1 | |
Fatigue, Weight decreased, Drug ineffective, Faeces soft, |
||||
ADALIMUMAB, ADALIMUMAB, LISINOPRIL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28